Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHA:688016)

Market Cap	10.66B
Revenue (ttm)	1.21B
Net Income (ttm)	502.10M
Shares Out	122.37M
EPS (ttm)	4.07
PE Ratio	21.40
Forward PE	18.96
Dividend	3.30 (3.80%)
Ex-Dividend Date	Nov 8, 2024

Volume	1,467,214
Average Volume	2,470,090
Open	86.34
Previous Close	86.50
Day's Range	85.28 - 86.95
52-Week Range	78.62 - 135.58
Beta	0.38
RSI	39.36
Earnings Date	Mar 29, 2025

About SHA:688016

Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, manufacturing, and sale of aortic and peripheral vascular medical devices in China and internationally. The company’s products include branched aortic stent graft system, thoracic stent graft system, abdominal aortic stent graft and delivery system, bifurcated stent graft system, and other stent graft system in surgical operation, as well as accessories, such as balloon inflation catheter. Shanghai MicroPort Endovascular MedTech Co., Ltd. was incorporated...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2012
• Employees: 908
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688016

Financial Performance

In 2024, SHA:688016's revenue was 1.21 billion, an increase of 1.61% compared to the previous year's 1.19 billion. Earnings were 502.10 million, an increase of 1.96%.